Prescription medicine
Oxidronate Brand names: Technescan
Oxidronate (Technescan) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the oxidronate FDA label on DailyMed (effective December 5, 2025); every oxidronate label on DailyMed.
Highlights of the record
FDA label of December 5, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageTechnescan HDP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adult and pediatric patients.
Forms and strengths
- 3.15 mg
Injection (powder) (lyophilized) for solution.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 135 through July 30, 2026
What is oxidronate used for?
From the label: indications and usageTechnescan HDP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adult and pediatric patients.
Source: FDA drug label (Technescan HDP), Curium US LLC, effective December 5, 2025 (SPL set 6fc2e41e-a1bf-4e0f-924a-88be0372d4af), via openFDA; the full label on DailyMed
Is there a generic for oxidronate (Technescan)?
No generic oxidronate is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What does the oxidronate label say about other medicines?
The oxidronate label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Betiatide | drug interactions | If considering Technescan HDP administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes based on the radiation dose from technetium Tc 99m oxidronate and the gestational timing of exposure. |
| Tetrakis copper tetrafluoroborate | drug interactions | Drug Interactions The biodistribution of technetium Tc 99m oxidronate may be altered in the presence of high levels of certain cations (iron, calcium, and aluminum). |
Source: FDA drug label (Technescan HDP), Curium US LLC, effective December 5, 2025 (SPL set 6fc2e41e-a1bf-4e0f-924a-88be0372d4af), via openFDA; the full label on DailyMed
What do FAERS reports show for oxidronate?
The FDA Adverse Event Reporting System holds 135 reports that list oxidronate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 18 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Oxidronate side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other